Please assess the completion status of the following clinical trial:

Trial Title: A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients demonstrate normal serum creatinine and no radiological evidence of a renal tumor.~OR~* Patients diagnosed with renal cancer and normal creatinine.~Exclusion Criteria:~* None.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: None): Patients demonstrate normal serum creatinine and no radiological evidence of a renal tumor.
- p 2 (Type: None): Patients diagnosed with renal cancer and normal creatinine.

Based on this trial design, predict the completion outcome and termination type (if applicable).